Finalized Changes to Medicare Payment Rules: Key Takeaways for Life Sciences Companies

Start
The Centers for Medicare & Medicaid Services (“CMS”) recently finalized a Medicare payment rule with significant implications for life sciences companies, particularly biotech and pharmaceutical manufacturers….
By: Ropes & Gray LLP
Previous Story

Design Patent Quick Facts

Next Story

Securities on a Sliding Scale: Inside “Project Crypto’s” New Approach to Digital Assets